Visual acuity improvement in adult amblyopic eyes with an iris-fixated phakic intraocular lens: Long-term results
Autor: | Jan A Venter, Steven C. Schallhorn, Barrie M. Collins, Martina Pelouskova |
---|---|
Rok vydání: | 2015 |
Předmět: |
Adult
Male Phakic Intraocular Lenses medicine.medical_specialty Visual acuity Distance visual acuity genetic structures Visual Acuity Iris Cell Count Amblyopia Refraction Ocular Phakic intraocular lens Myopic astigmatism Young Adult Postoperative Complications Lens Implantation Intraocular Ophthalmology Myopia medicine Humans Iris (anatomy) Intraoperative Complications Dioptre Retrospective Studies business.industry Endothelium Corneal Astigmatism Long term results Middle Aged eye diseases Sensory Systems Hyperopia medicine.anatomical_structure Optometry Hyperopic astigmatism Female Surgery sense organs medicine.symptom business Follow-Up Studies |
Zdroj: | Journal of Cataract and Refractive Surgery. 41:541-547 |
ISSN: | 0886-3350 |
DOI: | 10.1016/j.jcrs.2014.06.037 |
Popis: | To evaluate the effect of implantation of iris-fixated phakic intraocular lenses (pIOLs) (Artisan) in adult amblyopic eyes.Optical Express, London, United Kingdom.Retrospective case series.The study analyzed data from 5 years of follow-up of amblyopic eyes that were implanted with iris-fixated pIOLs and had a preoperative corrected distance visual acuity (CDVA) of 6/15 or worse. Visual acuity, refraction, endothelial cell count, and complications were assessed.Data for 103 eyes were analyzed as 2 groups. Group 1 comprised 82 eyes with myopia or myopic astigmatism, and Group 2 contained 21 eyes with hyperopia or hyperopic astigmatism. The mean preoperative sphere in Group 1 was -13.42 diopters (D) ± 5.62 (SD) with a mean cylinder of -2.35 ± 1.75 D. In Group 2, the mean sphere and cylinder were +6.77 ± 1.91 D and -2.63 ± 2.43 D, respectively. The mean CDVA improved from 0.51 ± 0.15 logMAR to 0.34 ± 0.16 logMAR (P.001) in Group 1 and from 0.54 ± 0.17 logMAR to 0.46 ± 0.14 logMAR in Group 2 (P.005). The safety index was 1.48 in Group 1 and 1.19 in Group 2. The efficacy index was 1.21 in Group 1 and 1.00 in Group 2. The mean gain in CDVA was statistically significantly greater in Group 1 (0.17 ± 0.14 logMAR) than in Group 2 (0.08 ± 0.11 logMAR). Two or more lines of CDVA were gained by 48.8% of eyes in Group 1 and by 19.0% of eyes in Group 2.The iris-fixated pIOL was a safe and effective option for improving visual acuity in adult amblyopic eyes.Dr. Schallhorn is a consultant to Abbott Medical Optics, Inc. No other author has a financial or proprietary interest in any material or method mentioned. |
Databáze: | OpenAIRE |
Externí odkaz: |